Gene · 8318
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. | Int J Mol Sci | 2022 | 36499305 | PubTator, text mining | PubMed |
| Two Distinct Modes of DNA Binding by an MCM Helicase Enable DNA Translocation. | Int J Mol Sci | 2022 | 36499022 | PubTator, text mining | PubMed |
| Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker. | Comput Math Methods Med | 2022 | 36466552 | PubTator, text mining | PubMed |
| Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach. | Hereditas | 2022 | 36451247 | PubTator, text mining | PubMed |
| SV40 T-antigen uses a DNA shearing mechanism to initiate origin unwinding. | Proc Natl Acad Sci U S A | 2022 | 36442086 | PubTator, text mining | PubMed |
| The Impact of Deleting Stem-Loop 1 of Epstein-Barr Virus-Encoded RNA 1 on Cell Proliferation. | Viruses | 2022 | 36423146 | PubTator, text mining | PubMed |
| Accurate Identification of DNA Replication Origin by Fusing Epigenomics and Chromatin Interaction Information. | Research (Wash D C) | 2022 | 36405252 | PubTator, text mining | PubMed |
| The non-catalytic role of DNA polymerase epsilon in replication initiation in human cells. | Nat Commun | 2022 | 36402816 | PubTator, text mining | PubMed |
| Identification of CKS2 and RRM2 as potential markers of vitiligo using bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36401415 | PubTator, text mining | PubMed |
| Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells. | J Biol Chem | 2022 | 36372230 | PubTator, text mining | PubMed |
| Contribution of Microhomology to Genome Instability: Connection between DNA Repair and Replication Stress. | Int J Mol Sci | 2022 | 36361724 | PubTator, text mining | PubMed |
| Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target gene. | Med Oncol | 2022 | 36352167 | PubTator, text mining | PubMed |
| DNA replication initiation shapes the mutational landscape and expression of the human genome. | Sci Adv | 2022 | 36351018 | PubTator, text mining | PubMed |
| In silico investigation of the role of vitamins in cancer therapy through inhibition of MCM7 oncoprotein. | RSC Adv | 2022 | 36349041 | PubTator, text mining | PubMed |
| Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia. | JCI Insight | 2022 | 36345943 | PubTator, text mining | PubMed |
| WEE1 inhibition augments CDC7 (DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastrophe. | Cancer Res Commun | 2022 | 36338546 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Cooperative assembly of p97 complexes involved in replication termination. | Nat Commun | 2022 | 36329031 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. | Biomed Res Int | 2022 | 36317111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8318/papers?page=16